Nanostructured Hybrid Matrix Device: An Engineered Approach for Localized Photodynamic Therapy in 9L/lacZ Cell Models
Related Experiment Video
Updated: Oct 31, 2026
Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models
Published on: June 16, 2022
Jéssica A R Ambrósio1, Janicy A Carvalho1, Letícia G M Pinto1
1Universidade do Vale do Paraiba, São José dos Campos 12244000, São Paulo, Brazil.
Abstract:
Gliosarcoma treatment remains a challenge due to its aggressiveness and high recurrence rates. This study describes the development and characterization of a novel hybrid drug delivery system (DDS) for localized photodynamic therapy (PDT). The system consists of a PVA/gelatin hydrogel encapsulated with hydroxyapatite microspheres (meHAp) loaded with chloroaluminum phthalocyanine (ClAlPc). SEM and FTIR analysis confirmed the successful incorporation of meHAp into the porous 3D polymeric network. The addition of meHAp increased the matrix's structural rigidity, adjusting the swelling degree and enabling a more controlled release of the photosensitizer (45% vs 94% in the control). Biological assays on 9L/lacZ gliosarcoma cells revealed high internalization and a 98% reduction in cell viability under PDT protocols. These results suggest that the meHAp-reinforced hydrogel system is a promising option for the localized treatment of brain tumors, providing a modified release of the photosensitizer.
